Results 101 to 110 of about 58,832 (240)

Adverse Renal Outcomes in Patients With Mesothelioma—A Territory‐Wide Real‐World Data

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Introduction Advances in mesothelioma management have translated into longer patient survival and different treatment‐related side effects including nephrotoxicity. The risk of developing adverse renal outcomes in patients with mesothelioma and associated risk factors remains undefined.
Wang Chun Kwok, James Chung Man Ho, Isaac Sze Him Leung, Desmond Yat Hin Yap   +3 more
wiley   +1 more source

Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion

, 2021
Xinying Li, Guannan Wu, Cen Chen, Yuan Zhao, Suhua Zhu, Xincui Song, Jie Yin, Tangfeng Lv, Yong Song   +8 more
openalex   +1 more source

Disseminated Invasive Aspergillosis in a Young Patient With Chronic Alcohol Use and Seemingly Preserved Immunocompetence: A Case Report

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Invasive aspergillosis, though typically seen in immunocompromised patients, can also affect immunocompetent individuals and mimic pulmonary malignancy. This case highlights the importance of considering fungal infections in the differential diagnosis of chronic respiratory symptoms, particularly in patients with risk factors such as heavy ...
Kumail Khandwala, Hiba Sawliha Syed, Shayan Sirat Maheen Anwar, Sehar Suleman, Khabab Abbasher Hussien Mohamed Ahmed   +4 more
wiley   +1 more source

Efficacy and Safety of Verapamil Through Indwelling Pleural Catheters in the Treatment of Malignant Pleural Effusion. [PDF]

, 2022
Yu Zhang, Feifei Wei, Yingwei Zhu, Yajing Liang, Zihui Xu, Tao Cheng, Kequn Xu   +6 more
openalex   +1 more source

Transdiaphragmatic Rupture of Hepatic Hydatid Cyst With Pleural Effusion and Daughter Cysts: A Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Trans‐diaphragmatic rupture of a hepatic hydatid cyst, can manifesting as a pleural effusion with daughter cysts, which could be an uncommon but serious complication. Prompt diagnosis through imaging and timely surgical intervention are critical to prevent life‐threatening outcomes in endemic areas.
Zahra Sadin, Manochehr Aghajanzadeh, Mohammadreza Sadin, Mohaya Farzin   +3 more
wiley   +1 more source

T‐cell receptor–like chimeric antigen receptor T cells targeting mesothelin: A first‐in‐human dose‐escalation trial for platinum‐resistant advanced ovarian cancer

Cancer, Volume 132, Issue 3, 1 February 2026.
Abstract Background Ovarian cancer remains a formidable therapeutic challenge due to late diagnosis, high recurrence rates, and limited treatment options. Mesothelin (MSLN) is highly expressed in ovarian cancer, making it a promising target for immunotherapy.
Yiyang Shan, Bo Ding, Feng Ji, Hao Lin, Weiwei Shi, Enxiu Wang, Chen Wang, Yang Shen   +7 more
wiley   +1 more source

Validation of on‐slide immunocytochemistry controls prepared from long‐term preserved prefixed cell suspensions

Cancer Cytopathology, Volume 134, Issue 2, February 2026.
Abstract Background On‐slide controls are essential for quality assurance in immunocytochemistry, yet their use in non–cell block cytology preparations remains a significant challenge. This study presents and evaluates a novel method for preparing on‐slide controls from long‐term prefixed cell suspensions, applicable to all types of cytology ...
Rúben Rodrigues Roque, Irena Srebotnik Kirbiš, Carla Sofia Castro Pinheiro, Rita Sattler Fagulha Martins, Vanessa Sofia Tavares, Saudade André, Ana Félix   +6 more
wiley   +1 more source

A Case Report of Promising Response to Combination Therapy With an Immune Checkpoint Inhibitor (Pembrolizumab) and Multi‐Targeted Tyrosine Kinase Inhibitor (Pazopanib) in Metastatic De‐Differentiated Chondrosarcoma

Cancer Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background We present the case of 72–year‐old male with metastatic de‐differentiated chondrosarcoma (“DDCS”). DDCS is a rare soft tissue cancer that carries a dismal prognosis in the metastatic stage, and is resistant to both traditional chemotherapy and radiotherapy. There is a distinct lack of proven systemic therapies. Case This case report
Matthew Youssef, Peter Grimison
wiley   +1 more source

Malignant Pleural Effusion

American Journal of Respiratory and Critical Care Medicine
Sharma S, Arora RD, Boster J.
europepmc   +2 more sources

Interventional management of recurrent malignant pleural effusion: state of the art in 2021

, 2021
Z. Hajnikova, P. Michalek, J. Votruba, R. Zahorec   +3 more
openalex   +1 more source